Hetero launches generic COVID-19 drug ‘Favipiravir’ at Rs 59 per tablet

By: |
Updated: Jul 29, 2020 1:44 PM

According to a press release issued by the city-based drug maker, Hetero has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI).

Hetero Labs, Hetero group, Favipiravir, COVID-19 drug, Favipiravir tablet price, covid 19 generic drug, Covifor, Remdesivir, covid 19 patient, Hetero Healthcare Ltd, USFDA, latets news on Hetero LabsAccording to a press release issued by the city-based drug maker, Hetero has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI. (Representational image: Reuters)

Hetero Labs, part of Hetero group on Wednesday announced the launch of generic Favipiravir in India under the brand name ‘Favivir.’ According to a press release issued by the city-based drug maker, Hetero has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI).

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of COVID-19.

It is an oral antiviral medication that has demonstrated positive clinical outcomes. Favivir improves treatment accessibility to a significant amount of COVID-19 patient population, which usually sustains mild to moderate symptoms.

Hetero’s Favivir is priced at Rs 59 per tablet and is marketed and distributed by Hetero Healthcare Ltd. The product is available from July 29 at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription, it said.

Backed by strong vertical integration capabilities, the drug is being manufactured at the company’s world-class formulation facility in India, which has been approved by stringent global regulatory authorities such as USFDA and the EU, among others, according to the release.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1India has extraordinary history of bringing out successful vaccines: K VijayRaghavan
2Delhi records 3,419 new COVID-19 cases from over 81K tests; positivity rate down to 4.2%
3Bharat Biotech says COVAXIN efficacious, safe, as Anil Vij tests positive for Covid-19